The 3rd Annual Blood-Brain Barrier Summit Returns in August 2021
pharmaphorum
APRIL 29, 2021
This Hanson Wade event is aimed at experts looking to deliver CNS drug candidates safely and successfully across the blood-brain barrier (BBB). Uncover advances in CNS gene therapy , new generation vectors for intravenous delivery, and the challenges of scaling up for CNS delivery beyond highly specialized centers.
Let's personalize your content